KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Chemed (CHE) Shares Outstanding (2016 - 2026)

Chemed filings provide 18 years of Shares Outstanding readings, the most recent being $13.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding fell 9.26% year-over-year to $13.3 million, compared with a TTM value of $13.3 million through Mar 2026, down 9.26%, and an annual FY2025 reading of $37.6 million, changed 0.46% over the prior year.
  • Shares Outstanding hit $13.3 million in Q1 2026 for Chemed, down from $37.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $37.6 million in Q4 2025, with the low at $13.3 million in Q1 2026.
  • Median Shares Outstanding over the past 5 years was $36.7 million (2022), compared with a mean of $26.6 million.
  • The largest YoY upside for Shares Outstanding was 150.91% in 2025 against a maximum downside of 60.78% in 2025.
  • Year by year, Shares Outstanding stood at $36.8 million in 2022, then grew by 1.05% to $37.2 million in 2023, then increased by 0.64% to $37.4 million in 2024, then rose by 0.46% to $37.6 million in 2025, then crashed by 64.69% to $13.3 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $13.3 million, $37.6 million, and $37.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.